Results 221 to 230 of about 125,944 (285)

New light on the HLA-DR immunopeptidomic landscape. [PDF]

open access: yesJ Leukoc Biol
Egholm Bruun Jensen E   +3 more
europepmc   +1 more source

Therapeutic potential of mesenchymal stem cells in peripheral nerve injuries in horses

open access: yesEquine Veterinary Education, Volume 38, Issue 5, Page 252-260, May 2026.
Summary Peripheral nerve injuries (PNI) in horses represent a significant clinical challenge, frequently associated with functional deficits and reduced athletic performance. Conventional therapeutic approaches, primarily based on anti‐inflammatory treatments and rehabilitation, offer limited efficacy, driving the search for innovative alternatives. In
L. V. de Oliveira Ferreira   +1 more
wiley   +1 more source

Why Is MS a More Frequent Complication of EBV Infection in Females?

open access: yesImmunological Reviews, Volume 339, Issue 1, May 2026.
ABSTRACT Multiple sclerosis (MS) is a T helper (Th) cell‐mediated disease that targets central nervous system (CNS) white matter. This disease affects three times more females than males. For many years, the etiology of MS was not well understood and the exact nature of the autoimmune reaction was speculative.
Shannon E. Dunn   +2 more
wiley   +1 more source

Collaboration is key for national preparedness: The hospital's role in whole blood rotation models

open access: yes
Transfusion, EarlyView.
Alexander Bowers   +4 more
wiley   +1 more source

Monocyte Chemokines Enhance Atherosclerotic Plaque Necrosis After Bacterial Kidney Infection

open access: yesThe FASEB Journal, Volume 40, Issue 7, 15 April 2026.
Cardiovascular event rates rise after acute infections. After a single pyelonephritis episode in Ldlr−/− mice, atherosclerotic plaque necrotic core size increased, mediated by chemokine receptor CCR2‐induced monocyte mobilization from the bone marrow.
Lena Possenriede   +10 more
wiley   +1 more source

Humanization of Pan-HLA-DR mAb 44H10 Hinges on Critical Residues in the Antibody Framework. [PDF]

open access: yesAntibodies (Basel)
Kassardjian A   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy